Author name: Fannie Pena

In 2023, the U.S. Food and Drug Administration (FDA) approved Opill, the first over-the-counter (OTC) daily oral contraceptive pill in American history. For the first time, people can purchase a highly effective hormonal birth control pill without a prescription, medical appointment, or insurance barrier. This milestone in reproductive healthcare gives millions of women and people

The explosion of interest in GLP-1 receptor agonists, most notably semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro), has transformed the landscape of obesity treatment. These once-weekly injections, originally developed for diabetes, are now among the most in-demand weight-loss drugs in the United States. Their proven ability to promote sustained weight reduction and improve metabolic health

Until recently, respiratory syncytial virus (RSV) was widely regarded as a childhood infection. That changed as surveillance revealed its substantial toll on older adults, especially those with heart or lung disease. Each year, RSV is responsible for an estimated 60,000–160,000 hospitalizations and 6,000–10,000 deaths among U.S. adults aged 65 and older. These figures are comparable

Introduction Respiratory syncytial virus (RSV) remains one of the most common and dangerous respiratory infections in early infancy. Nearly every child encounters RSV by the age of two, but for newborns and young babies, especially those under six months, the infection can cause severe bronchiolitis or pneumonia and lead to hospitalization. Each RSV season, which